A very good sleep is usually the stage for a positive day. But for that Almost quarter From American adults who must cope with mental illnesses Good night peace is usually difficult to know.

In patients with psychiatric diseases of Seeks To Mood disorders Like depression, disturbed sleep can often worsen the symptoms and make it harder to stick with treatment.

Despite the vital role of Zirkadian rhythms and sleeping game in addiction, Neuroscientists like me Only now begin to grasp the molecular mechanisms behind these effects.

Sleep and addictive drugs have one tangled relationship. Most addictive medication can change sleep-wake cycles, and sleep disorders in individuals who use drugs are related to the severity and relapse of the addiction. While this has a classic dilemma “chicken-or-EGG”, it also offers the chance to grasp how the Sleep-Diction connection could unlock recent treatments.

Circadian rhythms and health

At the middle of the connection between sleep and mental health is circadian rhythms: the interior clock of your body.

These rhythms align their body functions with their surroundings and synchronize their body day and night to the molecular level. This is completed by quite a few proteins that interact in a feedback loop and switch genes on and off in regular patterns to support specific functions. Although your sleep-wake cycles are essentially the most visible expression of circadian rhythms, these rhythms are Orchestrating most of your physiology.

If you may have ever traveled in time zones, you may have probably experienced a typical type of a circadian disorder as jet lag. This misalignment affects your sleep and concentration and might feel irritated.

While jetlag is a short lived annoyance, chronic circadian disorders can result in long -term health consequences, including an increased risk of Cardiovascular diseases and diabetes.

Circadian rhythms, sleep and opioid consumption

A essential focus of My laboratory Is on opioid dependency, an illness that nearly claimed 80,000 have been living per yr since 2021 within the USA and only has limited treatment options.

People who’re hooked on opioids Your sleep And theirs Corticotropin levelA key hormone that regulates stress. These disorders are related to many negative health consequences. In the short term, these disorders can affect Cognitive functions corresponding to attention and increase negative emotions. This will be done over time worsen mental and physical health. Studies on opioid dependency in mice show similar Disruptions in sleep And Different hormonal rhythms.

It is very important that poor sleep is common throughout the experience of an individual with opioid usage disorders, from energetic use to retreat from opioids and even during treatment. This complication can have profound consequences. Studies have associated the sleep problem with A 2.5 times increased risk of relapse Among those that treat themselves.

Turn off the clock for opioid dependency

Using the brain tissue of deceased donors and experiments in mice, my team identifies molecular changes related to psychiatric disorders in humans. We model these changes in mice to look at how they influence the severity and behavior of the disease.

Through genetic sequencing and computer modeling, my laboratory can profile all RNA molecules in a brain region and understand how their rhythmicity – the height and lows of their activity changes over the day – as a consequence of opioids. This provides a whole snapshot from which genes change in order that my team can integrate into the molecular mechanics that may advance the opioid dependency.

For example, we checked out two brain regions which are strongly connected to addiction: the Nucleus Accumbens and the Dorsolateral Prefrontal Cortex. We found that patients with opioid dependency had complete Different gene expression patterns In these brain regions in comparison with those without addiction. Some genes had taken over a very different rhythm of activity, while others had lost their rhythmicity as a complete.

Gene that lost the rhythm included those that were involved in various components of the molecular watch, and people related to the duration of sleep. This also shows how a circadian disorder is a symptom of opioid consumption and at the identical time reveals its underlying mechanisms.

In work that’s pending, my team focused on a big gene that lost the rhythmicity in patients with opioid dependency: NPAS2. This component of the molecular clock is extremely energetic and vital for the Nucleus Accumbens Sleep and circadian regulation. We found that the blocking of the functional NPAS2 Increased fentanylseecing behavior In mice. Interestingly, we observed that female mice were able to press a lever more often than male mice to get fentanyl what was documented Gender differences in opioid dependency Among people. In one other study we also found that the shortage of NPAS2 was lacking Worsened sleep disorders For mice that Fentanyl was administered.

Together, our results increase the role that Zirkadiane rhythms play in addiction. Future work can make clear whether the targeting of NPAS2 could treat opioid dependence symptoms. With prime quality sleep, it's not nearly waking up refreshed, but additionally for a reduced use of opioids and fewer overdoses.

In 2021, Julio Franco struggled with substance abuse for a decade. He was hooked on meth and suffered from psychosis. He had trouble distinguishing what was real and what wasn't. He rode his bike out and in of hospital emergency rooms.

“My body couldn’t take it anymore,” said Franco, 34.

The Redwood City native's first step toward lasting sobriety was a detox facility run by the nonprofit Star Vista in Burlingame, where he stayed for 3 weeks and weaned himself off methamphetamine with the assistance of trained staff. After he stabilized, he entered inpatient rehabilitation. Franco said he has since been clean and works as an addiction counselor for Star Vista.

Detoxification is a very important start line for addicts. But San Mateo County, the fifth largest within the Bay Area, has just one functioning detox facility after Star Vista closed its detox center in October.

The reason? The nonprofit now not has enough funding from the state health department to maintain its doors open, said Chief Clinical Officer Shareen Leland. Reforms to Medi-Cal, the health care provider for low-income Californians, modified the way in which providers like Star Vista are reimbursed. That went into effect in July in San Mateo County.

“This puts an incredible strain on the care network,” Leland said. “It’s a big deal.”

Medi-Cal, a serious funder of behavioral health services, used to cover the fee of cleansing. But due to CalAim, a large expansion of this system, providers in San Mateo County will now not be paid for outreach, meals and transportation for clients, or other costs they are saying are essential to programs.

Launched in 2022, CalAIM is an expansion of Medi-Cal that enables medical insurance to pay for certain things that are usually not considered traditional medical care — comparable to services that help homeless Californians find and maintain housing. Advocates say it has provided a much-needed injection of money into the state's overburdened homeless services system.

While CalAim increased coverage for housing and social services, it also modified the way in which treatment providers are paid for his or her services. For many, that will amount to a funding cut, advocates and a district official said.

A spokesman for the California Department of Public Health, which oversees CalAim, didn’t reply to a request for comment by press time.

The closures and cuts come as California prepares to implement Proposition 36, which took effect Wednesday. The voter-approved measure increases penalties for individuals with repeated shoplifting and drug convictions, with the goal of encouraging more people to hunt behavioral health treatment. This is widely expected to place much more pressure on the Bay Area's existing shortage of treatment providers.

According to Leland, Star Vista actually took a $177,000 cut this summer. In early December, Redwood City nonprofit Caminar closed a crisis shelter for severely mentally sick and addicted people just released from prisons and emergency rooms, Chief Executive Officer Mark Cloutier said.

Free at Last, a rehab program in East Palo Alto, also plans to chop costs, said executive director Gaynell Mays. She said the nonprofit has an 80% gap between the fee of providing inpatient and outpatient programs and what Medi-Cal pays now.

“It leaves us very vulnerable, like all other providers,” Mays said. “No one is happy.”

The concern amongst providers in San Mateo County follows similar cuts in Santa Clara County last yr as a result of CalAim. Momentum, certainly one of the most important nonprofit providers of behavioral health services in Santa Clara County, closed six of its programs and laid off 85 employees at the top of December 2023.

Because counties implement the reform at different speeds, the impact varies across the region and state. However, Cloutier said the brand new reimbursement rates under CalAim are also inadequate for providers in other Bay Area counties.

“It’s really, really sad,” Jei Africa, director of behavioral health and recovery services for San Mateo County, said of CalAim’s impact. “The new state rates resulting from CalAim payment reform have impacted many, many businesses in the county.”

Afrika said treatment options like closed detox in Burlingame are urgently needed and the county helps providers adapt. His office has asked CalAim administrators to recalculate payment rates to raised reflect the county's high costs of doing business, he said.

Still, Africa hopes the reform will make providers more efficient by reducing administrative costs and operating “leaner.”

For example, Africa said Star Vista's cleansing facility was only at 39% capability between July and October this yr. When county providers referred potential clients to them, staff sometimes refused to take them because the ability was short-staffed, he said. This is a nationwide behavioral health challenge.

But Leland said the county hasn't referred enough clients for detox. She said officials have suggested that Star Vista do more outreach to potential clients to fill beds.

The detox unit was small, with 4 beds in a warehouse-like constructing in a business district. Generally, two or three of those beds are occupied at a time, Leland said.

The clientele consisted of men like Franco with long-standing addictions to fentanyl or meth, who often got here from San Mateo Medical Center. Many had overdosed and needed medication, counseling and emotional support before they were ready for inpatient treatment, Leland said.

When the detox program led to October, those clients were referred to other programs, she said. Because of the funding shortfall, Star Vista can also be reducing its addiction treatment program for girls living “in really unsupportive situations” like homeless shelters, Leland said.

Ironically, Medi-Cal reform, which burdens providers in San Mateo County, broadly increases federal support for social services and vulnerable residents.

Under Gov. Gavin Newsom, CalAim launched a $12 billion expansion of Medi-Cal in 2022 to supply comprehensive services beyond what’s traditionally considered health care, comparable to housing. When the reform was implemented, about half of Medi-Cal's $133 billion annual budget was spent on 5% of the population covered: vulnerable individuals fighting homelessness, poverty, substance abuse and mental illness, reported CalMatters.

Proposition 1, which voters narrowly approved in March, would release $6.4 billion in bonds to fund hundreds of latest mental health treatment beds. But Cloutier said that can support construction, not the continued funds of treatment providers. He called on authorities to re-examine the impact of CalAim.

“There is a systematic problem here,” Cloutier said. “The state needs to address this problem.”

Originally published: December 29, 2024 at 6:00 am PST

Life within the digital world might be rewarding. It's convenient to order groceries for pickup, share photos or music, and stay in contact with family and friends regardless of the gap. However, it may even be tiring. The feeling of being consistently “on” and productive has led people to rethink their balance within the saturated digital world.

More than 70% of American adults are concerned about how technology affects their mental health and private relationships. This concern is reinforced by media highlighting people's unhealthy social media and phone habits.

What to do? There is a fluid line between healthy and unhealthy digital consumption. Some people feel the necessity to completely disconnect from the digital world with a purpose to understand this boundary. The idea of Digital detoxing is becoming increasingly popular. This practice is about consciously separating yourself from digital technologies with a purpose to achieve balance and digital well-being. Almost half of Americans report that they make a conscious effort to step away from their screens regularly.

But is that this attempt enough? That's no surprise 62% of Americans report feeling addicted on their devices and the Internet. Despite people's best efforts to unplug and find balance, research suggests that digital detoxes are common come up short.

Digital well-being is subjective. We research technology and Consumer behavior. Our current research studied the digital detox journeywhere people take a much-needed break from digital consumption to find what supports or sabotages those pursuing digital wellness. Our findings highlighted 4 key strategies to enhance the consequence of this journey to a healthier digital balance: substitute practices, social connections, mindfulness, and digital wellness as a journey.

1. Find substitute practices

We've found that feelings of withdrawal are quite common during a digital detox. For many, picking up the phone and scrolling has turn into such a ritual that they often don't even realize they're doing it. When bored or stressed, many individuals turn to their devices, just like one Adult pacifiers. Therefore, during a digital detox, finding an alternative choice to distract your mind and keep your hands busy might be crucial.

These substitute practices often include hobbies or activities that result in gaming. As adults, people sometimes forget what it seems like to rejoice. By separating fun out of your to-do list and interesting with gaming as an end in itself, you’ll be able to significantly reduce stress levels and increase your digital well-being.

2. Strengthening social bonds

Humans are social creatures by nature. In fact, tools like email, text messaging, and social media provide opportunities to extend social connections. However, this innate desire for connection, combined with people's addiction to technology, can result in feelings of FOMO – the fear of missing out – and anxiety during a digital detox.

The average adult is spending money now 70% less time with friends than 20 years ago. Digital devices provide connection, but lack parts of the experience, resembling the enjoyment of face-to-face contact and trust in others, which might be difficult to attain online. So while we’re a more connected society, relationships and folks suffer lonelier than ever.

Therefore, during a digital detox, it is crucial to fill the community with community, whether through existing friendships or by making latest ones. We recommend doing a digital detox with others because FOMO can rear its ugly head when your friend pulls out their phone while going out.

3. Emphasis on mindfulness

In today's fast-paced world, it may seem almost unimaginable to search out a moment to pause. Lots of experiences deprivation of lonelinesswhich suggests that individuals often don't have time to be alone with their very own thoughts. But the flexibility to simply be present can provide time for reflection and enable you take into consideration what makes you joyful and healthy. Finding moments to step back – to be still and still – can provide a much-needed recharge.

With adults who spend about 90% of their time indoorsBreaking the routine and getting outside can provide a more holistic perspective on personal and global well-being. In our study Yoga and meditation were common methods that detoxers found moments once they became more aware of their very own thoughts, which helped promote more conscious behavior.

4. View digital wellness as an ongoing journey

Ultimately, digital wellness is a journey. It is just not a checklist that when accomplished means you might be fulfilled.

Unfortunately, a single detox is just not enough to cure digital imbalance. Instead, a successful detox often leaves you feeling introverted and curious. Our research participants shared that relapses are common, especially once they don't set and monitor ongoing goals. What's necessary is that your needs change and evolve over time. In other words, what works now will not be what you would like in the longer term.

Willpower is just not enough. We recommend identifying specific goals related to your individual digital well-being. These should not productivity goals, but goals to be unproductive. The goal is to unwind in a more fulfilling way. Whether you intend a weekly game night with friends or go for a 10-minute walk without your phone, taking time to unwind is price it in the long term.

Researchers still have to learn more to support digital well-being. However, we should always keep in mind that individual differences play a vital role on this equation, meaning the trail to digital harmony is uniquely personal. As people move through their technology-saturated lives, it becomes clear that finding the fitting balance is a fancy, highly individual process.

The digital detox journey might be difficult, but many individuals find it rewarding in the long run. However, people should not machines. So recognizing your limitations and finding ways to reconnect with yourself and others during a detox can greatly increase your sense of humanity and your digital well-being.

There is growing consensus that for some patients, higher doses of a gold standard medication used to treat opioid addiction could also be higher than lower doses for maintaining patient health and treatment, particularly for those using fentanyl.

But whether someone has access to higher doses of buprenorphine — which curbs opioid cravings and withdrawal — will depend on where they live.

In most states, Medicaid — the biggest payer for substance use disorder treatment within the U.S. — limits the doses it pays to arbitrary limits, typically not more than 24 milligrams.

In some states, comparable to Tennessee, this value is as little as 16 milligrams. When “underdosing,” patients may experience symptoms which will make them return to the medications they are attempting to stop, risking an overdose and even death.

Providers say higher doses, sometimes as much as 32 milligrams, are vital given a drug supply dominated by highly potent fentanyl.

“It's probably the biggest challenge we face in our community because so many patients require higher doses to achieve the desired outcome that the drug is intended to achieve,” said Ryan Alexander, an addiction medicine physician and medical director of substance programming on the McNabb Center in Knoxville, Tennessee.

TennCare, Tennessee's Medicaid program, only pays for doses larger than 16 milligrams under certain circumstances.

“If you have a limit of 16 milligrams and the cravings are not controlled, you have poor control of the disease,” Alexander said. “This poses a risk of relapse and overdose.”

Restrictions on buprenorphine prescribing have received more attention as providers anticipate the increasing use of fentanyl and other synthetic opioids, which accounted for 70% of drug overdose deaths in 2022.

Several recent studies have shown that dosage limits may stand in the best way of higher care.

A study The study, published last month in JAMA Network Open, found that adults with opioid use disorder who received doses of buprenorphine greater than 24 milligrams had a lower risk of emergency room visits or behavioral health-related inpatient visits. It is consistent with other recent studies that reach similar conclusions.

Still, there appears to be a misconception that “less is more,” said Melissa Weimer, medical director of the Yale Addiction Medicine Consult Service, which treats hospitalized patients with substance use disorders.

“Less is not more. For these individuals, you need an adequate dose, and if they don't have an adequate dose, they are actually not protected from an opioid overdose and are more likely to undergo what you might call unsuccessful treatment with buprenorphine . “said Weimer. “I think that’s the change that’s happened with fentanyl, is that there can’t be a one-size-fits-all treatment.”

Medicaid programs often cite Food and Drug Administration labeling that states the dose needs to be as much as 24 milligrams and “doses greater than 24 mg have not been shown to provide clinical benefit.”

But doctors say the labeling doesn't keep pace with scientific understanding of the rapidly evolving opioid epidemic.

“If the drugs people are using are no longer prescription opioids or heroin, but illicit fentanyl with much higher potency, it seems reasonable that you need something stronger to deal with it,” Bobby Mukkamala said , President-elect of the American Medical Association Chair of the AMA's Substance Use and Pain Care Task Force.

Earlier this 12 months, the AMA House of Delegates, the legislative and policy-making body of the American Medical Association, passed a resolution supporting the power of physicians to prescribe buprenorphine doses above the FDA-approved label if approved by their prescriber Doctor advisable.

It was also urgent Federal agencies, manufacturers, medical organizations, and health plans must review dosage evidence and revise labels and guidelines accordingly.

Some states, comparable to Washington and the District of Columbia, recently increased their limits to 32 milligrams.

The FDA didn’t reply to a request for comment on next steps.

“These higher doses can improve outcomes for patients. It literally keeps people alive if you have the right dose. The obstacle to this is unscientific, bureaucratic regulations from insurance companies,” said Mukkamala.

©2024 CQ-Roll Call, Inc., All Rights Reserved. Visit cqrollcall.com. Distributed by Tribune Content Agency, LLC.

Meta Platforms Inc., Google, TikTok and Snap are facing lawsuits in federal court from school districts that blame their “addictive” apps for contributing to a mental health crisis amongst students.

The ruling by U.S. District Judge Yvonne Gonzalez Rogers on Thursday in Oakland, California, follows a contrary ruling June 7 by a Los Angeles Superior Court judge in favor of the businesses. The split may leave the platforms in search of damages in greater than 150 cases before Rogers, while poised to flee liability for claims in greater than 600 other cases filed in Los Angeles.

Rogers generally denied a motion to dismiss claims of negligence, but limited the scope of the allegations that will probably be pursued. It concluded that some claims are barred by Section 230 of the Communications Decency Act, a long-standing federal law that shields web firms from lawsuits.

Spokespeople for Google and Meta denied wrongdoing and said their firms had taken measures to make sure the security of young users on the platforms. Snap also cited its safety initiatives and pointed to research showing Snapchat has a positive impact on users' well-being. TikTok didn’t immediately reply to a request for comment.

RELATED: He prosecuted child abusers. Now he's taking motion against Meta for allegedly activating it

The ruling comes a bit greater than every week after Rogers ruled that Meta faces a lawsuit from dozens of state attorneys general for knowingly luring children on its Facebook and Instagram platforms. TikTok is confronted with similar claims from a coalition of states. Both firms denied wrongdoing.

The firms also face significant exposure from a whole lot of private injury lawsuits accusing them of designing their platforms to encourage teens to spend unhealthy amounts of time in front of screens. But the college cases have the potential to cause greater financial damage as each district tries to offset institutional costs with the negative impact that comes when a whole lot of individual students turn into involved in social media.

The school districts alleged that the businesses designed their platforms to addict children through the use of algorithms and features just like the “Like” button in ways in which were harmful to society – much like cigarette manufacturers who use their products designed to be addictive.

“Compulsive use”

Google spokesman Jose Castaneda said in a press release that the claims were unfaithful.

“Working with youth, mental health and parenting experts, we have developed services and policies to provide age-appropriate experiences for young people and robust controls for parents,” Castaneda said.

A Meta spokesperson said in a press release that the corporate disagrees with the court's decision.

“We've built numerous tools to support parents and teens, and recently announced that we're significantly transforming the Instagram experience for tens of millions of teens with new teen accounts. “This is a protected experience for teens that automatically limits who can contact them based on the content they see,” the statement said.

Lexi Hazam and Previn Warren, lead attorneys for the plaintiffs, hailed the ruling as a victory “for schools, teachers and administrators who are on the front lines of the nation's youth mental health crisis.”

“Students are struggling because of the addictive design of Instagram, Snapchat, TikTok and YouTube,” it said in a press release. “This means schools are struggling – their budgets are stretched and their educational missions are being diverted as they have to take on the additional responsibility of supporting children in crisis.”

Public nuisance

The judge said school district claims based on the legal theory of public nuisance, successfully used against sellers of nicotine vape pens, will probably be treated individually.

Clay Calvert, a law professor on the University of Florida, said the massive payouts within the Juul litigation could have led plaintiffs' lawyers to pursue similar theories within the social media cases.

“I think they see that large developments have potential,” he said.

But the professor also notes key differences between vape pens and social media, including First Amendment protections for content posted on social media.

Judges in Los Angeles and Oakland are overseeing separate personal injury lawsuits filed by teens and families that allege the social media firms are chargeable for widespread psychological distress and even suicides.

The federal case is In Re Social Media Adolescent Addiction/Personal Injury Products Liability Litigation, 22-md-03047, U.S. District Court, Northern District of California (Oakland).

For more stories like this, try Bloomberg.com

©2024 Bloomberg LP

Originally published: October 25, 2024 at 7:52 am

A bipartisan group of greater than a dozen state attorneys general is filing lawsuits against social media giant TikTok on Tuesday. A grievance accuses the corporate of deceiving users by claiming its app is secure for youngsters despite its “addictive” features and allegedly operates an unlicensed money transfer company.

States filing suit include: latest York and California and the District of Columbia.

“Our lawsuit aims to hold TikTok accountable for its harm to DC children,” he said Attorney General Brian Schwalb of the District of Columbia, in an interview with CNBC.

Schwalb's lawsuit alleges compulsive use of TikTok poses plenty of “significant” risks to the mental health of teenagers and youngsters, including depression, anxiety, sleep loss and body dysmorphia.

Schwalb called the app — which allows users to create, share and watch short videos — “digital nicotine” and said TikTok is “intentionally trying to get young people addicted to its platform.”

He said the app “is causing immense harm to an entire generation of young people.”

“TikTok’s unregulated and illegal virtual economy not only puts its profits above the health of children, but also enables the darkest and most corrupt sections of society to exploit vulnerable victims,” Schwalb said. “The company knows what is happening and has chosen to ignore it. This lawsuit seeks to put an end to his illegal, fraudulent and predatory behavior.”

TikTok didn’t immediately reply to a request for comment on the lawsuits, but said in an announcement

“We are proud of and remain deeply committed to the work we have done to protect young people. We will continue to update and improve our product,” TikTok said. “We provide robust protections, proactively remove suspected underage users, and have voluntarily introduced safety features such as default screen time limits, family pairing, and default privacy for minors under 16.”

“We have sought to work with the state attorneys general for over two years and it is incredibly disappointing that they have taken this step instead of working with us on constructive solutions to industry-wide challenges.”

More than half of young people between the ages of 13 and 17 within the US use the app. TikTok has greater than a billion lively users worldwide.

Schwalb's lawsuit, which alleges violations of D.C. consumer protection laws, accuses TikTok of “using algorithms and manipulative design features” to captivate young users by triggering bursts of dopamine of their impressionable brains.

“TikTok knows that its design features make the app addictive and keep users engaged for longer,” the lawsuit in DC Superior Court says.

“While this may be good for business, it has dangerous consequences for children.”

The grievance also states that in 2019, the corporate introduced “two new dangerous features”: a live streaming feature called TikTok LIVE and a virtual currency system called TikTok “Coins.”

“TikTok is characterized by its use of Coins – an unlicensed virtual currency,” the lawsuit says. “Users purchase coins to send virtual “gifts” during LIVE sessions, which streamers can money out for real money. TikTok is incentivizing users to go LIVE by promising that these money rewards will “get more popular.” [their] Content will likely be.'”

The lawsuit states that TikTok generates “significant revenue” from its coins and charges commissions of as much as 50% for every transaction.

The virtual currency app's deposit and withdrawal process is “a virtual money transfer system” that violates D.C. law by failing to acquire a required money transmitter license, the lawsuit says.

And “Although LIVE, including live streaming and gifting, currently has a minimum age requirement of 18 and older, TikTok knows that its lax age verification measures encourage U.S. minors to lie about their age to gain access,” it says in Schwalb's statement of claim.

The grievance also alleges that LIVE's design, including coins and gifts, “enables other serious harm to minors, including sexual exploitation.”

“TikTok is fully aware that these features together create an environment in which children are often sexually exploited by users, but has chosen to turn a blind eye in favor of increasing its profitability,” Schwalbs said in a press release Office.

TikTok's US headquarters are in Los Angeles, but the corporate maintains a big lobbying presence and office in Washington, DC

The company recently announced a partnership with the NHL's Washington Capitals hockey team to make use of TikTok's logo on its jerseys for away games for the upcoming season, the lawsuit says.

The lawsuit demands that TikTok be permanently barred from violating consumer protection laws and ordered to pay compensation to users and face civil penalties.

The lawsuits brought by Schwalb and the opposite attorneys general, who’re filing separate lawsuits in courts throughout the United States, comes at a legally difficult time for the corporate, which is owned by China-based ByteDance.

In September, Lawyers for TikTok argued in a federal appeals court that a brand new law that might ban the app by Jan. 19 unless ByteDance finds a non-Chinese buyer for the corporate was unconstitutional since it violated TikTok users' First Amendment rights.

The bill was approved by the House and Senate in April after members of Congress and others argued that the app posed a national security risk to the United States.

In particular, they claimed that the kind of data being collected might be used as a weapon by America's adversaries in Beijing if the 2 countries ever went to war.

The lawsuits are the newest in a series of civil suits by state attorneys general targeting social media corporations for alleged harm to children and other users of their popular apps.

By SOPHIE AUSTIN

SACRAMENTO – Starting in 2027, it is going to be illegal for social media platforms in California to knowingly serve addictive feeds to children without parental consent under a brand new law signed Friday by Democratic Gov. Gavin Newsom.

California follows New York State, which passed a law earlier this yr allowing parents to block their children from having social media posts suggested by a platform’s algorithm. Utah has passed laws lately aimed toward restricting children’s access to social media, but they’re Challenges in court.

The California law will take effect in a state that’s home to among the world's largest technology corporations. Similar suggestions have failed lately, but Newsom signed a first law within the country in 2022, online platforms won’t be allowed to make use of their users' personal information in ways that would harm children. This is a component of a growing initiative in states across the country to deal with the impact of social media on children's well-being.

“Every parent knows the damage social media addiction can do to their children – isolation from human contact, stress and anxiety, and endless hours wasted late into the night,” Newsom said in a press release. “With this law, California is helping to protect children and teens from intentionally designed features that encourage these destructive habits.”

The law prohibits platforms from sending notifications to minors without parental permission on weekdays between midnight and 6 a.m. and between 8 a.m. and three p.m., when children are frequently at college. The law also requires platforms to set children's accounts to personal by default.

Opponents of the law say it could inadvertently prevent adults who cannot prove their age from accessing content. Others argue it could jeopardize online privacy by requiring platforms to gather more details about their users.

The law defines an “addictive feed” as a web site or app “in which multiple media items created or shared by users are recommended, selected, or prioritized for display to a user, either simultaneously or sequentially, based in whole or in part on information provided by the user or otherwise associated with the user or the user’s device,” with some exceptions.

The issue gained renewed attention in June when US Surgeon General Vivek Murthy called on Congress to Require warnings on social media platforms and its impact on young people. Attorneys general in 42 states endorsed the plan in a letter to Congress last week.

Democratic Sen. Nancy Skinner of Berkeley, who authored the California law, said after lawmakers passed the bill last month: “The social media companies have designed their platforms to keep users addicted, especially our children.”

“With the passage of SB 976, the California Legislature sent a clear message: If social media companies don't act, it's our responsibility to protect our children,” she said in a press release.

Originally published: September 21, 2024 at 12:38 p.m.

A mobile team that gives drug treatments to individuals with opioid use disorders showed promising leads to Getting patients in Philadelphia to come back back for follow-up appointmentsbased on a peer-reviewed study I co-authored and published within the September 2024 issue of
Journal of Substance Use and Addiction Treatment.

The team, which incorporates a physician, a case manager and social employees with personal experience with substance use disorders, worked out of a van parked at six locations in neighborhoods with high fatal and non-fatal overdoses. The goal was to get patients same-day prescriptions for buprenorphine, a life-saving medicines for the treatment of opioid use disorders. The van is operated by Prevention Point Philadelphiaa non-profit harm reduction organization that supports the homeless and Substance use disorder.

It is very important that the “Bupe Busas patients and staff call it, reached a various patient population. Nearly 60% were black and 15% were Hispanic in the course of the period we collected our data. Most didn’t have a primary care physician or mental health provider.

After their first visit, 86% of patients accomplished no less than one follow-up visit and 69% accomplished 4 or more visits within the van.

When it got here to connecting patients to more traditional inpatient programs, similar to outpatient addiction treatment programs or buprenorphine prescribed in primary care settings, success was lower. Half of patients made it to no less than one outside appointment for a buprenorphine prescription and 30% made it to 2 or more visits to more traditional clinics.

Why it will be important

As Doctor and researcher in addiction medicineI feel lots about learn how to provide effective treatment to the patients who need it most.

Philadelphia has the best overdose death rate amongst major U.S. cities. The majority of individuals with opioid use disorder – each in Philadelphia and nationwide – received no treatment. In addition, there are persistent racial disparities in treatment, with black and Hispanic patients receive drug treatment less continuously for opioid use disorder. Overdose deaths amongst black Philadelphians have exceeded that of the white residents lately.

The only treatment for opioid use disorder is a drugs, specifically methadone and buprenorphine, often known by the brand name Suboxone. These medications prevent withdrawal symptoms, control opioid cravings, and reduce the chance of overdose if a relapse occurs. Essentially, these medications break the cycle of addiction and permit people to feel normal and deal with the remaining of their lives.

What other research is being carried out

A lot of research papers describe Barriers in addiction treatmentThese include barriers to obtaining medical health insurance coverage, regulations that limit treatment options, and an absence of trained treatment staff.

In addition, many patients have no idea who to show to for addiction treatment, feel poorly treated there or are subjected to rigid and cumbersome Requirements for treatmentThese demands may include each day visits or regular counseling sessions, which may make it difficult to work, care for youngsters, or attend to other necessary life activities.

How we work

The Bupe bus is a so-called low-barrier or Low-threshold modelLow-barrier models aim to bring treatment on to the individuals who need it, without additional bureaucracy. This approach is predicated on the popularity that individuals more more likely to take medication for opioid use disorders in the event that they can access them quickly and these medications are effective without intensive consultation or other requirements And whether persons are abstinent from drugs or not.

This approach is consistent with the way in which healthcare providers treat other conditions similar to diabetes or hypertension. However, it’s less common within the treatment of substance abuse.

Opioid overdose deaths within the United States rose dramatically from 2014 to today, each Philadelphia, PennsylvaniaAnd Camden, New Jerseyhave cemented their popularity as focal points of the crisis.

In Philadelphia over 1,170 people died of an opioid overdose in 2022the last 12 months for which complete data can be found. More than 300 other died just behind the bridge in Camden County.

Studies show that for many individuals with opioid use disorder, abuse starts with prescription painkillers.

As neuroscientists who Effects of addictive substances on the brainWe are working to higher understand why some persons are at higher risk of developing opioid dependence and addiction when taking prescription opioids.

In addition, we attempt to seek out higher treatment methods that may reduce drug cravings and forestall relapse amongst users in rehab.

Gender differences and opioid addiction

There is evidence that biological sex may play a job in each the tendency toward opioid addiction and the danger of relapse.

For example, the outcomes show that ladies are prescribed and use prescription opioids more often than men. You too switch faster out of from initial use to compulsive abuse.

In addition, some studies have found that ladies self-report when attempting to stay clean stronger craving for opioids than men and might experience more severe withdrawal symptoms. This suggests that ladies can also be at higher risk of relapse.

What might underlie these gender differences in opioid abuse and relapse? One possible factor is the differences between men and girls in the degrees of the important thing sex hormones: testosterone, estrogen and progesterone.

Because estrogen and progesterone levels naturally fluctuate in women throughout the menstrual cycle and through different life stages equivalent to pregnancy and menopause, we investigate whether opioid use and cravings change as levels of those hormones change.

Hormones and drug cravings

To decipher the connection between hormonal fluctuations and opioid rewards, many researchers have turned to rodent models. Rats are particularly well suited as a model organism because their reproductive cycle, the estrous cycle, is brief and lasts only 4 to 5 days. In addition, the pattern of fluctuations in estrogen and progesterone levels in rats is much like your entire human menstrual cycle.

In the Loweth Laboratorywe found that the craving for cocaine vary throughout the estrous cycleIn particular, cocaine cravings increase across the time of ovulation, after estrogen and progesterone levels peak.

In people, The craving for cocaine can also be stronger across the time of ovulation, when estrogen levels are elevated.

However, much less is thought about whether these hormonal fluctuations similarly affect opioid reward or craving.

Hormones and pain relief

Our current knowledge of the hormonal influence of opioids on humans is essentially based on studies that focused on their pain-relieving effects.

Although there are some conflicting reports, the information seem to point that opioid-induced pain relief in women is biggest through the menstrual cycle phase before ovulationThis happens when estrogen levels rise and progesterone levels are low.

Opioid drugs relieve pain by binding to and activating proteins called opioid receptors at various nodes within the brain and spinal cord. The brain also produces its own natural version of opioids, called endogenous opioids. Research shows that increased estrogen levels can increase each. the variety of opioid receptors and that Concentrations of certain endogenous opioids in numerous parts of the brain.

These changes may contribute to differences in opioid-induced pain relief across the menstrual cycle.

Hormones and opioid rewards and cravings

We and other researchers are working to find out whether estrogen and progesterone levels also affect the rewarding effects of prescription opioids or the cravings for these drugs.

In a series of studies, scientists trained rats to press a lever to receive intravenous heroin infusions. The researchers found that the rats took less heroin during a phase of the estrous cycle before ovulationif estrogen and progesterone levels were elevated.

Follow-up studies It later turned out that the rise in estrogen, but not in progesterone, was liable for this decline in heroin consumption.

Recent evidence suggests that this phenomenon can also apply to prescription opioids. Manvich Laboratorywe found that the rewarding effect of the prescription opioid painkiller oxycodone decreases in an analogous way during cycle phases around ovulation, during which Estrogen and progesterone levels are rising or have just fallen of peak levels.

Meanwhile, unpublished studies from the Loweth lab have found similar reductions in oxycodone cravings over the course of the estrous cycle in rats. Another recent study using barely different methods no effects found of the estrous cycle on the need for oxycodone.

Such discrepancies underscore the necessity for further research to find out exactly how and when hormones affect the danger of relapse amongst former prescription opioid users.

This information could play a crucial role in how healthcare professionals prescribe opioid medications – possibly making an allowance for each biological sex and hormonal status – to reduce the danger of transition to prescription opioid abuse.

Ultimately, such efforts could reduce the variety of opioid addicts and help combat the continuing opioid crisis.

More than 29.5 million Americans ages 12 and older had Alcohol use disorder — the medical term for the disease commonly often called alcoholism — in 2022, when essentially the most recent national data was released.

The disorder is characterised by a pattern of heavy alcohol consumption with lack of control over alcohol consumption despite negative social, occupational, or health consequences.

Deaths on account of excessive alcohol consumption have increased sharply lately, to 178,000 within the United States in 2021, up from 138,000 five years earlier. The strongest increase occurred in the course of the first 12 months of the COVID-19 pandemic.

Alcohol is liable for more deaths as overdoses from opioids and all other substances combined and is liable for 1 in 5 of all deaths in people aged 20 to 49. Alcohol-related deaths can have various causes. These include the long-term effects of alcohol, similar to cancer, liver disease, and heart disease, in addition to its short-term effects, similar to automobile accidents, poisoning, and suicide.

There are many effective treatment options for alcohol use disorders, including psychotherapy, peer support groups similar to: Anonymous alcoholics And SMART recoveryand medicine. I’m a clinical psychologist and neuroscientistand over the past 15 years my research has focused on Evaluation of medicines for alcohol use disorder.

Over this time, I actually have observed significant changes within the scientific understanding and treatment of alcohol use disorders. I’m optimistic that our existing medicines can reach more individuals with this condition, that we are able to higher goal these medicines to the patients most probably to learn from them, and that latest effective medicines are on the horizon.

Alcohol abuse disorders are largely undertreated

With the Beginning of the opioid epidemic Over the past twenty years, medications for opioid use disorders similar to methadone and buprenorphine entered the general public consciousness. However, medications for alcohol addiction are less well-known to the general public and are used less steadily.

While 22% of patients suffer from opioid use disorder Receive medication for treatmentThe rate of drug treatment for alcohol use disorders is far lower. Less than 10% of individuals with alcohol addiction receive treatment every year, and lower than 3% receive medication for it.

Unfortunately, many individuals suffer from alcohol addiction don't recognize it the severity of their alcohol use and its impact on others, and plenty of are unaware that effective medications can be found.

Medications approved to treat alcohol addiction

As of May 2024, three medications have been approved by the Food and Drug Administration to treat alcohol use disorder. The oldest and best known of those drugs is Disulfiram – sold under the brand name Antabuse – a connection that was first utilized in the American rubber industry.

In 1937, a rubber factory doctor observed that employees exposed to disulfiram showed hostile reactions to alcohol, including nausea, vomiting and tachycardia – a rapid heartbeat. Subsequent research found that disulfiram inhibits alcohol metabolism, resulting in… Accumulation of acetaldehyde. This causes many hangover symptoms immediately after drinking alcohol. which makes drinking unpleasant.

Disulfiram is effective in reducing alcohol consumption However, it should be taken orally day by day, limiting its usefulness if patients don’t take it on this schedule.

A recently FDA approved – and simpler – Drug for alcohol addiction is the opioid receptor antagonist naltrexone. It blocks opioid receptors and prevents opioids—each “exogenous” opioid drugs and “endogenous” opioids produced within the brain—from activating these receptors.

It may be surprising that an opioid receptor antagonist is effective in treating alcohol use disorders. However, opioids actually play a key role in alcohol's effect on the neurotransmitter Dopaminewhich underlies the nice effects of alcohol and most other drugs.

Naltrexone reduces dopamine release from alcoholblock a few of them nice effect of drinking. It can be vital reduces cravings for alcohol, probably through its effect on dopamine, which is released in response to signals similar to the sight, smell and taste of alcohol. Naltrexone is effective in reducing heavy alcohol consumption but less effective with complete abstinence from alcohol.

Naltrexone might be taken orally day by day or injected once a month, making it a greater option for patients who can have difficulty taking an oral medication day by day. Interestingly too Reduces heavy alcohol consumption when taken sporadically before expected drinking opportunities. The same opioid antagonist, nalmefene, is approved within the European Union in alcohol addiction.

The third drug approved by the FDA, Acamprosate, also reduces alcohol cravings, but its molecular effects are less well understood. Results of European clinical studies can be found It has been shown to assist people reduce their alcohol consumptionbut results from US studies were less positive.

“Off-label” medications

Several medications have shown encouraging effects on alcohol consumption in randomized controlled trials but should not yet approved by the FDA for the treatment of alcohol use disorders. Instead, they’re used “off-label,” meaning doctors use their discretion to prescribe them for an unapproved indication. The Most promising Medication are approved for the treatment of epilepsy.

These medications look like partially effective for alcohol use disorders Reducing alcohol withdrawal symptoms, a dangerous condition that happens in some people after they abruptly stop heavy drinking. In its most severe form, alcohol withdrawal causes hyperreactivity of the autonomic nervous system, auditory and visual hallucinations, and seizures. These medications include gabapentin, topiramate and baclofen, the latter approved in France in alcohol addiction.

Precision medicine

Unfortunately, each FDA-approved and unapproved alcohol abuse medications have relatively small effects on alcohol consumption. On average, these medications cause individuals who drink heavily most days of the week—that’s, 4 or more drinks per day for ladies, five or more for men—to accomplish that less one or two days per week. However, this average varies significantly between patients – some see a big effect and others see no profit.

A significant current focus of research funded by the National Institute on Alcohol Abuse and Alcoholism on medications for alcohol use disorders has been the usage of a “Precision medicine“Approach to discover patients for whom a specific drug is more more likely to have a big effect.

For example, my work And Other' has found that folks who each drink heavily and smoke cigarettes usually tend to profit from naltrexone. This could also be on account of the additive effects of alcohol and nicotine on dopamine release in reward-related brain regions makes these people particularly more likely to profit from a drug that may block dopamine release from alcohol. Naltrexone also appears to be simpler in people whose drinking is motivated by the will for positive, rewarding effects of alcoholconsistent with its ability to scale back these effects.

Finally, recent research suggests that gabapentin could also be simpler People with a history of alcohol withdrawal. Genes that predict drug effects are also being evaluated, but up to now none have had consistent effects across studies.

At the horizon

The seek for effective medications to treat alcohol addiction is a vital area of ​​current research. The National Institute on Alcohol Abuse and Alcoholism funds a cross-location research programduring which my laboratory participates and has evaluated quite a lot of promising drug candidates Phase 2 and three clinical trials. The FDA typically requires that drugs display effectiveness in a minimum of two Phase 3 trials before they’re approved for a brand new use.

A resurgence of Interest in psychedelic compounds in psychiatry has led to preliminary data suggesting that psilocybin, the energetic ingredient in hallucinogenic mushrooms, Reduce alcohol consumption together with psychotherapy.

Finally, Anecdotal reports of decreased interest in alcohol They have sparked a number of interest in patients taking GLP-1 agonists—drugs that mimic the consequences of glucagon-like peptide 1 (GLP-1), a hormone the body produces after eating Potential of those medications to treat alcohol use disordersThese include Ozempic and Wegovy, that are FDA approved for diabetes and weight reduction. My lab and a number of other others are Conducting trials with these medicationswith results expected in the subsequent one to 2 years.

Alcohol addiction is a devastating disease that urgently needs higher treatments. Approved and off-label medications are currently available. As research into latest medications continues, patients should seek them out Providers who use evidence-based treatments have the best likelihood of success in relation to gaining control over their alcohol consumption.